恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
恒瑞医药(600276) 利润表
单位:万元
报表日期2021-09-302021-06-302021-03-312020-12-312020-09-30
一、营业总收入2,019,896.851,329,754.27692,905.492,773,459.871,941,312.51
营业收入2,019,896.851,329,754.27692,905.492,773,459.871,941,312.51
二、营业总成本1,531,885.331,016,293.93516,135.002,128,204.631,453,340.86
营业成本272,856.73175,422.0291,039.84334,868.97238,454.98
营业税金及附加15,689.2910,586.585,755.3125,695.9519,577.76
销售费用699,580.34466,513.65233,015.62980,252.41690,734.32
管理费用153,858.15116,395.0362,903.68306,665.83188,485.34
财务费用-24,294.88-10,674.18-8,202.26-18,174.35-18,323.35
研发费用414,195.69258,050.83131,622.81498,895.82334,411.81
资产减值损失----------
公允价值变动收益-4,565.84-1,042.91-118.991,649.70-461.44
投资收益16,807.5810,214.075,041.6234,142.4525,589.07
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润507,304.65322,710.45180,051.07700,707.23519,328.92
加:营业外收入306.45157.69114.97106.90101.04
减:营业外支出14,727.8510,103.782,890.0011,266.1415,295.93
其中:非流动资产处置损失----------
四、利润总额492,883.25312,764.36177,276.03689,548.00504,134.03
减:所得税费用73,693.1746,524.3727,672.4858,658.6979,859.60
五、净利润419,190.08266,239.99149,603.55630,889.31424,274.43
归属于母公司所有者的净利润420,720.10266,759.51149,654.76632,838.32425,859.21
少数股东损益-1,530.02-519.52-51.21-1,949.01-1,584.78
六、每股收益
基本每股收益(元/股)0.66000.42000.28001.19000.8000
稀释每股收益(元/股)0.66000.42000.28001.19000.8000
七、其他综合收益-85.78-29.28282.33-1,170.48-655.48
八、综合收益总额419,104.30266,210.70149,885.88629,718.83423,618.95
归属于母公司所有者的综合收益总额420,648.96266,755.74149,906.40631,705.91425,211.99
归属于少数股东的综合收益总额-1,544.66-545.03-20.51-1,987.08-1,593.03
下载全部历史数据到excel中 返回页顶